Treace Medical Concepts (TMCI) Research & Development (2020 - 2026)

Treace Medical Concepts has reported Research & Development for 7 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 16.9% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (down 7.42% YoY), and the FY2025 full-year result was $20.3 million, down 1.49% from the prior year.
• Research & Development for Q1 2026 stood at $4.6 million, up from $4.5 million in the prior quarter.
• The five-year high for Research & Development was $5.6 million in Q1 2025, with the low at $3.0 million in Q2 2022.
• Historically, Research & Development has averaged $4.4 million across 5 years, with a median of $4.5 million in 2025.
• Annual changes were most pronounced in 2022 — Research & Development soared 63.38% — and 2026, when it decreased 16.9%.
• Treace Medical Concepts' Research & Development stood at $3.7 million in 2022, then rose by 10.75% to $4.2 million in 2023, then advanced by 25.48% to $5.2 million in 2024, then declined by 12.82% to $4.5 million in 2025, then climbed by 1.76% to $4.6 million in 2026.
• The last three Research & Development figures came in at $4.6 million (Q1 2026), $4.5 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.